Table 4 Comparison of clinical characteristics between elderly patients with localized-OPLL and diffuse-OPLL (age ≥ 70 years).
Variable | Localized-OPLL (n = 10) | Diffuse-OPLL (n = 25) |
|---|---|---|
Current age (years) | 75 (73–88) | 80 (70–86) |
Age of OPLL symptom onset (years) | 65 (50–80) | 70 (20–80) |
Age of onset < 50 years (%) | 10.0 | 16.0 |
Male (%) | 90.0 | 16.7 |
Current BMI (kg/m2) | 26.3 (19.1–31.2) | 25.4 (15.6–34.7) |
Current BMI ≥ 25.0 kg/m2 (%) | 75.0 | 60.0 |
Current BMI ≥ 27.5 kg/m2 (%) | 37.5 | 24.0 |
Current BMI ≥ 30.0 kg/m2 (%) | 25.0 | 12.0 |
Current BMI ≥ 35.0 kg/m2 (%) | 0 | 0 |
Platelet (109 /L) | 218 (159–309) | 215 (126–362) |
AST (U/L) | 20 (19–33) | 19 (12–48) |
ALT (U/L) | 26.4 ± 17.0 | 15.6 ± 10.7 |
AST/ALT | 0.9 (0.4–1.6) | 1.4 (0.8–3.6) |
Comorbidity (%) | ||
Myocardial infarction | 10.0 | 0 |
Angina pectoris | 0 | 8.0 |
Hypertension | 50.0 | 68.0 |
Hyperlipidemia | 50.0 | 48.0 |
Diabetes mellitus | 20.0 | 36.0 |
Cancer | 20.0 | 20.0 |
Renal disease | 0 | 0 |
Gout | 0 | 12.0 |
Drinking alcohol habits (%) | 30.0 | 20.0 |
